["{\n\"step_by_step_thinking\": \"The question is about combining 2-methoxyestradiol with chemotherapeutics to reduce dosages in human ovarian cancer treatment. The relevant documents are [Effectiveness of transdermal administration of 17-beta-estradiol in the management of menopause], [Synthetic progestins in combined treatment of cancer of the uterine body], A rationale for the use of non-steroidal anti-androgens in the management of prostate cancer, Hormonal therapy of breast cancer: new approaches and concepts, and [The chemotherapy of urologic neoplasms]. None of these documents discuss 2-methoxyestradiol or its combination with chemotherapeutics for ovarian cancer treatment. Therefore, it is not possible to determine if the combination can reduce dosages based on provided information.\",\n\"answer_choice\": \"B\"\n}"]